Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Forst

Showing results (31-40 of 96) with videos related to

Pageof 10
Sort By:
Acta Diabetologica|February 23, 2013
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetesF Pistrosch, C Köhler, F Schaper, et al.
Clinical Laboratory|October 24, 2008
Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery diseaseA Pfützner, N Marx, D Walcher, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serumA Pfützner, T Forst, A Ambrosch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesionsT Forst, A Pfützner, P Kann, et al.
Metabolism: Clinical and Experimental|October 27, 1999
Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuriaB Fruehwald-Schultes, W Kern, J Beyer, et al.
Current Medical Research and Opinion|October 26, 2013
Performance of blood glucose meters in compliance with current and future clinical ISO15197 accuracy criteriaA Pfützner, C Hengesbach, F Demircik, et al.
The Journal of Clinical Investigation|May 29, 1998
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitusT Forst, T Kunt, T Pohlmann, et al.
Diabetes & Metabolism|November 18, 2015
Effect of canagliflozin on liver function tests in patients with type 2 diabetesL A Leiter, T Forst, D Polidori, et al.
Electromyography and Clinical Neurophysiology|July 28, 1999
Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitusP P Urban, T Forst, M Lenfers, et al.
Current Medical Research and Opinion|June 19, 2014
Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic controlA Pfützner, S Dissel, C Forkel, et al.
Pageof 10

Showing results (31-40 of 96) with videos related to

Sort By:
Pageof 10
Acta Diabetologica|February 23, 2013
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetesF Pistrosch, C Köhler, F Schaper, et al.
Clinical Laboratory|October 24, 2008
Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery diseaseA Pfützner, N Marx, D Walcher, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Determination of anti GAD65 autoantibodies with an ELISA before and after standardization with the new international reference serumA Pfützner, T Forst, A Ambrosch, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1995
Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesionsT Forst, A Pfützner, P Kann, et al.
Metabolism: Clinical and Experimental|October 27, 1999
Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuriaB Fruehwald-Schultes, W Kern, J Beyer, et al.
Current Medical Research and Opinion|October 26, 2013
Performance of blood glucose meters in compliance with current and future clinical ISO15197 accuracy criteriaA Pfützner, C Hengesbach, F Demircik, et al.
The Journal of Clinical Investigation|May 29, 1998
Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitusT Forst, T Kunt, T Pohlmann, et al.
Diabetes & Metabolism|November 18, 2015
Effect of canagliflozin on liver function tests in patients with type 2 diabetesL A Leiter, T Forst, D Polidori, et al.
Electromyography and Clinical Neurophysiology|July 28, 1999
Incidence of subclinical trigeminal and facial nerve involvement in diabetes mellitusP P Urban, T Forst, M Lenfers, et al.
Current Medical Research and Opinion|June 19, 2014
Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic controlA Pfützner, S Dissel, C Forkel, et al.
Pageof 10